ABCC8 and type 2 diabetes mellitus: As the widely used drugs for the treatment of patients with type 2 diabetes, SUs could bind specifically to the SUR1 subunit, then closing the KATP channel via an ATP-independent mechanism and therefore increasing the insulin secretion of β cells [52].